Trial Profile
A Phase III, Multi-center, Open-label, Randomized Study to Assess the Efficacy and Safety of Org 37462 Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for IVF or ICSI, Using a Long Protocol of Triptorelin as a Reference Treatment
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2022
Price :
$35
*
At a glance
- Drugs Ganirelix (Primary) ; Chorionic gonadotropin; Recombinant follicle-stimulating hormone; Triptorelin
- Indications Infertility
- Focus Therapeutic Use
- Sponsors Organon
- 27 Jan 2010 Actual end date changed from Nov 2008 to Dec 2008 as reported by ClinicalTrials.gov.
- 25 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2008 New trial record.